Clinical Oncology
Volume 21, Issue 5 , Pages 376-379 , June 2009

Size Does Matter: Can we Reduce the Radiotherapy Field Size for Selected Cases of Anal Canal Cancer Undergoing Chemoradiation?

Received 23 January 2008 ,Revised 13 January 2009 ,Accepted 22 January 2009.

References 

  1. Ryan DP, Compton C, Mayer RJ. Medical progress: carcinoma of the anal canal. N Engl J Med. 2000;342:792–800
  2. Papillon J, Montbarbon JF. Epidermoid carcinoma of the anal canal: a series of 276 cases. Dis Colon Rectum. 1987;30:324–333
  3. Cummings BJ, Keane TJ, O'Sullivan B, et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys. 1991;21:1115–1125
  4. Nigro ND, Vaitkevicius VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1984;17:354–358
  5. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomised trial of the EORTC Radiotherapy and Gastro-intestinal Cooperative Groups. J Clin Oncol. 1997;15:2040–2049
  6. Bosset JF, Pavy JJ, Roelofsen F, Bartelink H, for the EORTC Radiotherapy Gastrointestinal Cooperative Groups . Combined radiotherapy and chemotherapy for anal cancer. Lancet. 1997;349:205–206
  7. UKCCCR Anal Cancer Trial Working Party . Epidermoid anal cancer results from the UKCCCR randomised trial of radiotherapy alone vs radiotherapy, 5-fluorouracil, and mitomycin C. Lancet. 1996;348:1049–1054
  8. Clark M, Hartley A, Geh JI. Cancer of the anal canal – review. Lancet Oncol. 2004;5:149–157
  9. Jephcott CR, Paltiel C, Hay J. Quality of life after non-surgical treatment of anal carcinoma: a case control study of long term survivors. Clin Oncol. 2004;16:530–535
  10. ACT II Trial Protocol. The second UK phase II Anal Cancer Trial. Cancer Research UK & UCL Cancer Trials Centre; London.
  11. Sobin LH, Wittekind C. TNM classification of malignant tumours, 6th edn, Springer-Verlag; New York, 2002.
  12. Newman G, Calverley DC, Acker BD, et al. The management of carcinoma of the anal canal by external beam radiotherapy, experience in Vancouver 1971–1988. Radiother Oncol. 1992;25:196–202
  13. Gerard JP, Chapet O, Samiei F, et al. Management of inguinal lymph node metastasis in patients with carcinoma of the anal canal: experience in a series of 270 patients treated in Lyon and review of the literature. Cancer. 2001;92:77–84
  14. Das P, Bhatia S, Eng C, et al. Predictors and pattern of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys. 2007;68:794–800
  15. Cotter SE, Grigsby PW, Siegel BA, et al. FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys. 2006;65:720–725
  16. Damin DC, Rosito MA, Schwartsmann G. Sentinel lymph node in carcinoma of the anal canal: a review. Eur J Surg Oncol. 2006;32:247–252
  17. Andreyev HJN. Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol. 2007;19:790–799
  18. Anal Cancer Trials. Cancer Research UK & UCL Cancer Trials Centre, London. Newsletter Summer 2006.

PII: S0936-6555(09)00046-6

doi: 10.1016/j.clon.2009.01.015

Clinical Oncology
Volume 21, Issue 5 , Pages 376-379 , June 2009

Article Tools

* Image Usage & Resolution